Skip to content
TheChatArchiveThe Chat Archive
Geminigemini-2.5-flash-preview-04-17-grounding· GoogleHugging Face LMArena Search Arena 24K

czy to prawda (dostałem info od kolego prawaka), że Tusk sprytnie zamiast 160 mln euro z…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Perplexitysonar-pro-high’s answer.
  1. User

    czy to prawda (dostałem info od kolego prawaka), że Tusk sprytnie zamiast 160 mln euro z KPO przeznaczyć na przemysł farmaceutyczny wytwarzanie substancji czynnych, przesunął na zakup używanych elektryków z Niemiec?

  2. Gemini Assistant

    Based on the search results, here's a breakdown of the situation:

    1. Funds for Pharmaceutical Industry: The original Polish KPO plan included funds for the development of the pharmaceutical industry, specifically for the production of active pharmaceutical ingredients (API). The amount mentioned in several sources is around 139.5 mln euro (slightly less than 160 mln euro, but close enough to be the figure the user is referencing)[1][2][3]. This was intended to improve Poland's drug security, as much of the API is currently imported from outside Europe, mainly Asia[1][2][3].

    2. Reallocation of Pharmaceutical Funds: The current Polish government (led by Donald Tusk) has decided to withdraw from or reallocate these specific funds for API production from the KPO. The reason cited by the Ministry of Development and Technology is that the deadline for utilizing these funds (by mid-2026) is unrealistic given the delays in preparing the necessary reforms and investment processes under the previous government[2][3][4]. There was also dissatisfaction from the industry regarding the proposed form of support (loans instead of grants)[6]. This decision has been criticized by some, including opposition politicians like Marcelina Zawisza[1][7][2].

    3. Funds for Electric Vehicles: Separately, the Polish government plans to launch a program called "NaszEauto" providing subsidies for the purchase and leasing of electric vehicles, both new and used[8][9][10]. The budget for this program is substantial, mentioned as 1.6 billion PLN (approximately 370 million euro) from the KPO[8][10][11].

    4. Link between the two: Some sources explicitly connect the reallocation of the 140 mln euro from pharmaceutical API production to the funding for electric vehicles, including used ones[1][7]. Poseł Marcelina Zawisza is quoted stating that the 140 mln euro originally for API production was moved to subsidize the purchase of electric cars, including used ones, implying these could be imported from countries like Germany[1][7]. While one article suggests the idea of including used cars in the subsidy program came from the European Commission, the final decision on the shape of the program, including potential limitations on used cars, rests with the Polish Ministry of Climate and Environment[16]. The Ministry reportedly leans towards prioritizing new cars, but the possibility of subsidizing used electric vehicles, including those from Germany, has been publicly discussed and reported[13][14][15].

    Conclusion:

    The information your friend shared contains elements that are true, but the phrasing "przesunął na zakup używanych elektryków z Niemiec" (shifted to buy used electric cars from Germany) might be an oversimplification or politically charged framing.

    • Is it true that funds originally for the pharmaceutical industry (API production) from KPO were reallocated? Yes, sources indicate around 139.5-140 mln euro intended for API production were indeed withdrawn or reallocated from that specific purpose within the KPO[1][2][3].
    • Were these funds specifically moved to buy used electric cars from Germany? The funds for electric vehicle subsidies (including potentially used ones) come from the KPO and amount to a much larger sum (1.6 billion PLN / ~370 mln euro)[8][10][11]. While it's reported that the 140 mln euro from the pharmaceutical sector was reallocated within the KPO to the pool for electric vehicle subsidies[1][7], it wasn't a direct 1:1 transfer specifically for used cars from Germany. The electric vehicle subsidy program covers new and potentially used cars[8][9][10], and given the market, many used electric cars imported to Poland do come from Germany[14].

    So, while the specific 140 mln euro was moved out of the pharmaceutical API segment of KPO and into the broader pool of funds for electric vehicle subsidies (a much larger pool), it's not accurate to say the entire 160 mln euro (or 140 mln euro) was only used to buy used electric cars specifically from Germany. The funds contribute to a larger subsidy program for electric vehicles, which may include subsidies for used cars, some of which could be imported from Germany. The primary reason cited for abandoning the API project was the unrealistic deadline, not a deliberate choice to prioritize used cars over pharmaceutical production[2][3][4].

    Therefore, the core claim about the reallocation of funds from the pharmaceutical sector to electric vehicles within the KPO is based on factual events (reallocation from API, allocation to EVs), but the details (exact amount, sole purpose being used cars from Germany) are likely a simplification or distortion.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.